Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.07
+0.08 (1.26%)
Jul 28, 2026, 1:15 PM EDT - Market open
Harvard Bioscience Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 85.53 | 86.55 | 94.14 | 112.25 | 113.34 | 118.9 |
Revenue Growth | -6.42% | -8.06% | -16.14% | -0.96% | -4.68% | 16.46% |
Gross Profit Gross Profit Growth | 49.97 | 49.91 | 54.77 | 66.07 | 60.82 | 67.65 |
Operating Income Operating Income Growth | -0.09 | -48.58 | -6.21 | 1.89 | -6.93 | 2.07 |
Net Income Net Income Growth | -9.78 | -56.7 | -12.41 | -3.42 | -9.52 | -0.29 |
Earnings Per Share EPS Growth | -2.17 | -12.80 | -2.80 | -0.80 | -2.30 | -0.10 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 37.94 | 38.97 | 41.74 | 48.21 | 49.91 | 49.83 |
Americas - Other Americas - Other Growth | 3.25 | 3.23 | 3.6 | 3.52 | - | - |
Europe, Middle East and Africa Europe, Middle East and Africa Growth | 27.15 | 26.71 | 28.41 | 33.28 | - | - |
China China Growth | 11.04 | 10.97 | 13.3 | 18.49 | 16.39 | 13.5 |
Asia - Other Asia - Other Growth | 6.15 | 6.68 | 7.1 | 8.77 | - | - |
Total Total Growth | 85.53 | 86.55 | 94.14 | 112.25 | 113.34 | 118.9 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7.1 | 8.61 | 4.11 | 4.28 | 4.51 | 7.82 |
Total Debt Total Debt Growth | 42.57 | 42.75 | 43.34 | 41.36 | 54.24 | 56.96 |
Net Cash (Debt) Net Cash Growth | -35.47 | -34.14 | -39.23 | -37.07 | -49.73 | -49.14 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.96 | -7.69 | -9.01 | -8.74 | -12.01 | -12.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3.08 | 6.73 | 1.44 | 14.03 | 1.15 | 1.26 |
Capital Expenditures CapEx Growth | -1.17 | -1.26 | -2.64 | -1.79 | -1.59 | -1.2 |
Free Cash Flow Free Cash Flow Growth | 1.91 | 5.47 | -1.2 | 12.24 | -0.44 | 0.07 |
Free Cash Flow Growth | 273.78% | - | - | - | - | -99.18% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.42% | 57.67% | 58.18% | 58.86% | 53.66% | 56.90% |
Operating Margin | -0.10% | -56.13% | -6.60% | 1.69% | -6.12% | 1.74% |
Pretax Margin | -19.58% | -76.48% | -18.19% | -6.24% | -10.08% | -1.97% |
Profit Margin | -19.45% | -75.69% | -18.97% | -7.01% | -10.38% | -2.10% |
FCF Margin | 2.23% | 6.32% | -1.28% | 10.90% | -0.39% | 0.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 7.87 | 17.58 | 23.26 | 17.87 | 22.03 |
P/FCF Ratio | 14.14 | 54.67 | - | 189.68 | - | 43292.10 |
PS Ratio | 0.32 | 3.46 | 9.88 | 20.68 | 10.06 | 24.39 |